申请人:BioAxone BioSciences, Inc.
公开号:US20190015404A1
公开(公告)日:2019-01-17
Disclosed are therapeutic compositions including BA-1076 and/or BA-2057, methods of their use in the treatment of ophthalmological disorders. The therapeutic compositions may further include an IOP-lowering prostaglandin. The methods may further include administration of an IOP-lowering prostaglandin.